Cargando…
Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial
SIMPLE SUMMARY: Pancreatic cancer patients who undergo curative surgery are still likely to recur. We therefore analyzed the data of the 493 patients from the PRODIGE 24-CCTG PA 6 trial, which validated the benefit of adjuvant mFOLFIRINOX regimen over gemcitabine after pancreatic adenocarcinoma rese...
Autores principales: | Legrand, Théo, Salleron, Julia, Conroy, Thierry, Marchal, Frédéric, Thomas, Jacques, Monard, Laure, Biagi, James Jim, Lambert, Aurélien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406034/ https://www.ncbi.nlm.nih.gov/pubmed/36010938 http://dx.doi.org/10.3390/cancers14163945 |
Ejemplares similares
-
Development of a Clinical–Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial
por: Egea, Julie, et al.
Publicado: (2022) -
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
por: Lambert, Aurélien, et al.
Publicado: (2017) -
The prodigal son
por: Britten, Benjamin, 1913-1976
Publicado: (1990) -
Cilia - the prodigal organelle
por: Beales, Phil, et al.
Publicado: (2012) -
The origin of genetic instability in CCTG repeats
por: Lam, Sik Lok, et al.
Publicado: (2011)